(Q57419199)

English

Estimate of deaths due to valvular insufficiency attributable to the use of benfluorex in France

article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Estimate of deaths due to valvular insufficiency attributable to the use of benfluorex in France (English)

0 references

Mahmoud Zureik

2

0 references

Agnès Fournier

object named as

Agnès Fournier

series ordinal

1

0 references

publication date

9 February 2012

0 references

published in

Pharmacoepidemiology and Drug Safety

0 references

volume

21

0 references

issue

4

0 references

page(s)

343-351

0 references

cites work

The effects of acute ethanol feeding and of chronic benfluorex administration on the activities of some enzymes of glycerolipid synthesis in rat liver and adipose tissue

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPDS.3213

retrieved

21 January 2018

Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPDS.3213

retrieved

21 January 2018

Drugs and valvular heart disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPDS.3213

retrieved

21 January 2018

Fenfluramine-like cardiovascular side-effects of benfluorex.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPDS.3213

retrieved

21 January 2018

Valvular heart disease associated with benfluorex therapy: results from the French multicentre registry.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPDS.3213

retrieved

21 January 2018

Valvular heart disease associated with benfluorex

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPDS.3213

retrieved

21 January 2018

Benfluorex and unexplained valvular heart disease: a case-control study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPDS.3213

retrieved

21 January 2018

Benfluorex and valvular heart disease: a cohort study of a million people with diabetes mellitus

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPDS.3213

retrieved

21 January 2018

Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPDS.3213

retrieved

21 January 2018

Risk of valvular heart disease associated with use of fenfluramine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPDS.3213

retrieved

21 January 2018

Fenfluramine and phentermine and cardiovascular findings: effect of treatment duration on prevalence of valve abnormalities

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPDS.3213

retrieved

21 January 2018

Valvular heart disease associated with benfluorex therapy: high prevalence in patients with unexplained restrictive valvular heart disease.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPDS.3213

retrieved

21 January 2018

Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine/fenfluramine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPDS.3213

retrieved

21 January 2018

Clinical and echocardiographic follow-up of patients previously treated with dexfenfluramine or phentermine/fenfluramine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPDS.3213

retrieved

21 January 2018

An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo. Sustained-Release Dexfenfluramine Study Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPDS.3213

retrieved

21 January 2018

Appetite suppressants and valvular heart disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPDS.3213

retrieved

21 January 2018

Clinical outcome of mitral regurgitation due to flail leaflet

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPDS.3213

retrieved

21 January 2018

Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study)

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPDS.3213

retrieved

21 January 2018

Prevalence and determinants of valvulopathy in patients treated with dexfenfluramine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPDS.3213

retrieved

21 January 2018

Identifiers

0 references

0 references

(Q57419199)

Estimate of deaths due to valvular insufficiency attributable to the use of benfluorex in France

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)